vs
Side-by-side financial comparison of ALLIANCE ENTERTAINMENT HOLDING CORP (AENT) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
ALLIANCE ENTERTAINMENT HOLDING CORP is the larger business by last-quarter revenue ($368.7M vs $207.8M, roughly 1.8× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 2.5%, a 54.8% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-16.9M).
Alliance Atlantis Communications Inc. was a media company that operated primarily as a specialty service provider in Canada. Primarily based in Toronto, Alliance Atlantis also had offices in Halifax, Los Angeles, London, Dublin, Madrid, Barcelona, Shannon, and Sydney.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
AENT vs IDYA — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $368.7M | $207.8M |
| Net Profit | $9.4M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 4.7% | 52.2% |
| Net Margin | 2.5% | 57.4% |
| Revenue YoY | -6.3% | — |
| Net Profit YoY | 32.8% | 330.1% |
| EPS (diluted) | $0.18 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $368.7M | — | ||
| Q3 25 | $254.0M | $207.8M | ||
| Q2 25 | $227.8M | — | ||
| Q1 25 | $213.0M | — | ||
| Q4 24 | $393.7M | — | ||
| Q3 24 | $229.0M | $0 | ||
| Q2 24 | $236.9M | $0 | ||
| Q1 24 | $211.2M | $0 |
| Q4 25 | $9.4M | — | ||
| Q3 25 | $4.9M | $119.2M | ||
| Q2 25 | $5.8M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $7.1M | — | ||
| Q3 24 | $397.0K | $-51.8M | ||
| Q2 24 | $2.5M | $-52.8M | ||
| Q1 24 | $-3.4M | $-39.6M |
| Q4 25 | 4.7% | — | ||
| Q3 25 | 4.2% | 52.2% | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | -0.3% | — |
| Q4 25 | 2.5% | — | ||
| Q3 25 | 1.9% | 57.4% | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | -1.6% | — |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $0.10 | $1.33 | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $0.14 | — | ||
| Q3 24 | $0.01 | $-0.60 | ||
| Q2 24 | $0.05 | $-0.68 | ||
| Q1 24 | $-0.07 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $117.6M | $1.1B |
| Total Assets | $434.1M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $4.3M | $920.0M | ||
| Q2 24 | $1.1M | $701.7M | ||
| Q1 24 | $1.6M | $698.8M |
| Q4 25 | $117.6M | — | ||
| Q3 25 | $108.1M | $1.1B | ||
| Q2 25 | $103.2M | — | ||
| Q1 25 | $97.4M | — | ||
| Q4 24 | $95.6M | — | ||
| Q3 24 | $88.0M | $1.2B | ||
| Q2 24 | $87.6M | $931.7M | ||
| Q1 24 | $85.1M | $935.3M |
| Q4 25 | $434.1M | — | ||
| Q3 25 | $383.0M | $1.2B | ||
| Q2 25 | $361.2M | — | ||
| Q1 25 | $349.4M | — | ||
| Q4 24 | $401.7M | — | ||
| Q3 24 | $395.7M | $1.2B | ||
| Q2 24 | $340.8M | $973.7M | ||
| Q1 24 | $324.0M | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.5M | $142.2M |
| Free Cash FlowOCF − Capex | $-16.9M | $142.2M |
| FCF MarginFCF / Revenue | -4.6% | 68.4% |
| Capex IntensityCapex / Revenue | 0.1% | 0.0% |
| Cash ConversionOCF / Net Profit | -1.76× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-1.4M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.5M | — | ||
| Q3 25 | $2.7M | $142.2M | ||
| Q2 25 | $10.7M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $25.3M | — | ||
| Q3 24 | $-11.6M | $-49.2M | ||
| Q2 24 | $9.7M | $-32.9M | ||
| Q1 24 | $20.0M | $-43.8M |
| Q4 25 | $-16.9M | — | ||
| Q3 25 | $2.4M | $142.2M | ||
| Q2 25 | $10.7M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-11.6M | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | $20.0M | $-45.1M |
| Q4 25 | -4.6% | — | ||
| Q3 25 | 0.9% | 68.4% | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 9.4% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | -1.76× | — | ||
| Q3 25 | 0.56× | 1.19× | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | -29.31× | — | ||
| Q2 24 | 3.85× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
